Sarah K. Harm

502 total citations
23 papers, 296 citations indexed

About

Sarah K. Harm is a scholar working on Biochemistry, Hematology and Management of Technology and Innovation. According to data from OpenAlex, Sarah K. Harm has authored 23 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Biochemistry, 13 papers in Hematology and 8 papers in Management of Technology and Innovation. Recurrent topics in Sarah K. Harm's work include Blood transfusion and management (14 papers), Blood donation and transfusion practices (8 papers) and Blood groups and transfusion (7 papers). Sarah K. Harm is often cited by papers focused on Blood transfusion and management (14 papers), Blood donation and transfusion practices (8 papers) and Blood groups and transfusion (7 papers). Sarah K. Harm collaborates with scholars based in United States, United Kingdom and Canada. Sarah K. Harm's co-authors include Mark H. Yazer, Joan Cid, Jonathan H. Waters, Jay S. Raval, Meghan Delaney, James P. AuBuchon, Darrell J. Triulzi, Nancy M. Dunbar, Zbigniew M. Szczepiorkowski and Mark H. Yazer and has published in prestigious journals such as American Journal of Clinical Pathology, Transfusion and Human Immunology.

In The Last Decade

Sarah K. Harm

21 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah K. Harm United States 10 163 141 91 77 71 23 296
Henry Ddungu Uganda 11 125 0.8× 127 0.9× 68 0.7× 124 1.6× 38 0.5× 17 356
Jean‐Marc Payrat Sweden 12 267 1.6× 192 1.4× 123 1.4× 45 0.6× 41 0.6× 20 392
Enric Contreras Spain 9 77 0.5× 151 1.1× 44 0.5× 74 1.0× 30 0.4× 11 301
C. Barrasso United States 9 258 1.6× 214 1.5× 145 1.6× 91 1.2× 44 0.6× 16 458
Robert A. DeSimone United States 9 52 0.3× 60 0.4× 38 0.4× 42 0.5× 32 0.5× 41 252
P. Fabrigli France 5 161 1.0× 143 1.0× 70 0.8× 16 0.2× 70 1.0× 18 274
Íñigo Romón Spain 9 78 0.5× 58 0.4× 43 0.5× 32 0.4× 41 0.6× 29 255
Hamna J. Qureshi United Kingdom 6 59 0.4× 203 1.4× 16 0.2× 63 0.8× 19 0.3× 7 279
Xavier Ortı́n Spain 9 57 0.3× 176 1.2× 12 0.1× 32 0.4× 12 0.2× 20 277
Matthew Yan Canada 8 17 0.1× 77 0.5× 14 0.2× 29 0.4× 27 0.4× 26 194

Countries citing papers authored by Sarah K. Harm

Since Specialization
Citations

This map shows the geographic impact of Sarah K. Harm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah K. Harm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah K. Harm more than expected).

Fields of papers citing papers by Sarah K. Harm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah K. Harm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah K. Harm. The network helps show where Sarah K. Harm may publish in the future.

Co-authorship network of co-authors of Sarah K. Harm

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah K. Harm. A scholar is included among the top collaborators of Sarah K. Harm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah K. Harm. Sarah K. Harm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Metcalf, Ryan A., Claudia S. Cohn, Elizabeth S. Allen, et al.. (2022). Current advances in transfusion medicine 2021: A critical review of selected topics by the AABB Clinical Transfusion Medicine Committee. Transfusion. 62(7). 1435–1445.
2.
Seheult, Jansen N., Jeannie Callum, Meghan Delaney, et al.. (2022). Rate of D‐alloimmunization in trauma does not depend on the number of RhD‐positive units transfused: The BEST collaborative study. Transfusion. 62(S1). S185–S192. 8 indexed citations
3.
Reeves, Hollie M., Erin Meyer, Sarah K. Harm, et al.. (2021). Neonatal and pediatric blood bank practice in the United States: Results from the AABB pediatric transfusion medicine subsection survey. Transfusion. 61(8). 2265–2276. 9 indexed citations
4.
Harm, Sarah K., et al.. (2021). Risk of ABO-Incompatible Plasma From Non-ABO-Identical Components. Transfusion Medicine Reviews. 35(4). 118–122. 5 indexed citations
5.
Pagano, Monica B., Elizabeth S. Allen, Stella T. Chou, et al.. (2020). Current advances in transfusion medicine: a 2019 review of selected topics from the AABB Clinical Transfusion Medicine Committee. Transfusion. 60(7). 1614–1623. 1 indexed citations
6.
Wilcox, Rebecca, et al.. (2019). Design and Implementation of a Pathology-Specific Handoff Tool for Residents. Academic Pathology. 6. 1533839314–1533839314. 2 indexed citations
7.
Harm, Sarah K. & Nancy M. Dunbar. (2019). Immunologic risks of whole blood: ABO compatibility, D alloimmunization, and transfusion‐related acute lung injury. Transfusion. 59(S2). 1507–1511. 2 indexed citations
8.
Korte, Dirk de, Louis Thibault, Wiebke Handke, et al.. (2018). Timing of gamma irradiation and blood donor sex influences in vitro characteristics of red blood cells. Transfusion. 58(4). 917–926. 20 indexed citations
9.
10.
Harm, Sarah K., Mark H. Yazer, Carolina Bonet Bub, et al.. (2018). Seasonal variability is not observed in the rates of high anti‐A and anti‐B titers in plasma, apheresis platelet, and whole blood units tested by different methods. Transfusion. 59(2). 762–767. 13 indexed citations
11.
Harm, Sarah K., Zbigniew M. Szczepiorkowski, & Nancy M. Dunbar. (2018). Routine use of Day 6 and Day 7 platelets with rapid testing: two hospitals assess impact 1 year after implementation. Transfusion. 58(4). 938–942. 11 indexed citations
12.
Yazer, Mark H., Pouneh Beizai, Nicole L. Draper, et al.. (2016). The Crossmatch/Issue Ratio. American Journal of Clinical Pathology. 146(2). 238–243. 7 indexed citations
13.
Tran, Minh‐Ha, et al.. (2016). Massive Transfusion Protocol. American Journal of Clinical Pathology. 146(3). 319–323. 5 indexed citations
14.
Harm, Sarah K., et al.. (2014). A Centralized Recipient Database Enhances the Serologic Safety of RBC Transfusions for Patients With Sickle Cell Disease. American Journal of Clinical Pathology. 141(2). 256–261. 45 indexed citations
15.
Cid, Joan, Sarah K. Harm, & Mark H. Yazer. (2013). Platelet Transfusion - the Art and Science of Compromise. Transfusion Medicine and Hemotherapy. 40(3). 160–171. 47 indexed citations
16.
Harm, Sarah K., et al.. (2012). Changes in Mechanical Fragility and Free Hemoglobin Levels after Processing Salvaged Cardiopulmonary Bypass Circuit Blood with a Modified Ultrafiltration Device. Journal of ExtraCorporeal Technology. 44(1). 21–25. 7 indexed citations
17.
Harm, Sarah K., et al.. (2012). Routine use of a rapid test to detect bacteria at the time of issue for nonleukoreduced, whole blood–derived platelets. Transfusion. 53(4). 843–850. 21 indexed citations
18.
Harm, Sarah K., Mark H. Yazer, & Jonathan H. Waters. (2012). Changes in hematologic indices in caucasian and non-caucasian pregnant women in the United States. The Korean Journal of Hematology. 47(2). 136–136. 14 indexed citations
19.
20.
Harm, Sarah K., et al.. (2011). Haemolysis and sublethal injury of RBCs after routine blood bank manipulations. Transfusion Medicine. 22(3). 181–185. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henry Ddungu Breakdown of academic impact, for papers by Jean‐Marc Payrat Breakdown of academic impact, for papers by Enric Contreras Breakdown of academic impact, for papers by C. Barrasso Breakdown of academic impact, for papers by Robert A. DeSimone Breakdown of academic impact, for papers by P. Fabrigli Breakdown of academic impact, for papers by Íñigo Romón Breakdown of academic impact, for papers by Hamna J. Qureshi Breakdown of academic impact, for papers by Xavier Ortı́n Breakdown of academic impact, for papers by Matthew Yan
Rankless by CCL
2026